112 related articles for article (PubMed ID: 1680491)
21. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
22. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
[TBL] [Abstract][Full Text] [Related]
23. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and immunosensitivity of ex vivo human carcinomas: interferon gamma and tumour necrosis factor alpha treatment of tumour cells potentiates their interaction with autologous blood lymphocytes.
Vánky F; Hising C; Sjöwall K; Larsson B; Rodriguez L; Orre L; Klein E
Cancer Immunol Immunother; 1995 Oct; 41(4):217-26. PubMed ID: 7489564
[TBL] [Abstract][Full Text] [Related]
25. Interactions between autologous CD4+ and CD8+ T lymphocytes and human squamous cell carcinoma of the head and neck.
Okada K; Yasumura S; Muller-Fleckenstein I; Fleckenstein B; Talib S; Koldovsky U; Whiteside TL
Cell Immunol; 1997 Apr; 177(1):35-48. PubMed ID: 9140094
[TBL] [Abstract][Full Text] [Related]
26. Synergistic effect of IFN-gamma and TNF-alpha on expression of immune molecules and antigen presentation by Schwann cells.
Gold R; Toyka KV; Hartung HP
Cell Immunol; 1995 Oct; 165(1):65-70. PubMed ID: 7671325
[TBL] [Abstract][Full Text] [Related]
27. Functional analysis of intercellular adhesion molecule-1-expressing human thyroid cells.
Weetman AP; Freeman M; Borysiewicz LK; Makgoba MW
Eur J Immunol; 1990 Feb; 20(2):271-5. PubMed ID: 1968836
[TBL] [Abstract][Full Text] [Related]
28. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).
Wang P; Vánky F; Klein E
Int J Cancer; 1992 Jul; 51(6):962-7. PubMed ID: 1386348
[TBL] [Abstract][Full Text] [Related]
29. Evidence for tumor necrosis factor-alpha involvement in the optimal induction of class I allospecific cytotoxic T cells.
Robinet E; Branellec D; Termijtelen AM; Blay JY; Gay F; Chouaib S
J Immunol; 1990 Jun; 144(12):4555-61. PubMed ID: 2161875
[TBL] [Abstract][Full Text] [Related]
30. Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes.
Batten P; Yacoub MH; Rose ML
Immunology; 1996 Jan; 87(1):127-33. PubMed ID: 8666424
[TBL] [Abstract][Full Text] [Related]
31. Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysis.
Goedegebuure PS; Braakman E; Segal DM; Vreugdenhil RJ; Bolhuis RL
Int Immunol; 1990; 2(12):1213-20. PubMed ID: 1982501
[TBL] [Abstract][Full Text] [Related]
32. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
33. Auto-tumor recognition following in vitro induction of MHC antigen expression on solid human tumors: stimulation of lymphocytes and generation of cytotoxicity against the original MHC-antigen-negative tumor cells.
Vánky F; Stuber G; Rotstein S; Klein E
Cancer Immunol Immunother; 1989; 28(1):17-21. PubMed ID: 2462466
[TBL] [Abstract][Full Text] [Related]
34. Interferon-gamma and tumor necrosis factor-alpha treatment of ex vivo human carcinoma cells potentiates their interaction with allogeneic lymphocytes.
Vánky F; Hising C; Sjöwall K; Larsson B; Klein E
J Interferon Cytokine Res; 1996 Mar; 16(3):201-7. PubMed ID: 8697142
[TBL] [Abstract][Full Text] [Related]
35. Effects of IFN-gamma and interleukin-1beta on major histocompatibility complex antigen and intercellular adhesion molecule-1 expression by 9L gliosarcoma: relevance to its cytolysis by alloreactive cytotoxic T lymphocytes.
Schiltz PM; Gomez GG; Read SB; Kulprathipanja NV; Kruse CA
J Interferon Cytokine Res; 2002 Dec; 22(12):1209-16. PubMed ID: 12581494
[TBL] [Abstract][Full Text] [Related]
36. Human tumor-lymphocyte interaction in vitro. VI. Specificity of primary and secondary autologous lymphocyte-mediated cytotoxicity.
Vánky FT; Vose BM; Fopp M; Klein E
J Natl Cancer Inst; 1979 Jun; 62(6):1407-13. PubMed ID: 86634
[TBL] [Abstract][Full Text] [Related]
37. Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer.
Liu Z; Guo B; Lopez RD
J Gastroenterol Hepatol; 2009 May; 24(5):900-11. PubMed ID: 19175829
[TBL] [Abstract][Full Text] [Related]
38. Role of central nervous system microvascular pericytes in activation of antigen-primed splenic T-lymphocytes.
Balabanov R; Beaumont T; Dore-Duffy P
J Neurosci Res; 1999 Mar; 55(5):578-87. PubMed ID: 10082080
[TBL] [Abstract][Full Text] [Related]
39. "Neutral allografts"--lack of allogeneic stimulation by cultured human cells expressing MHC class I and class II antigens.
Theobald VA; Lauer JD; Kaplan FA; Baker KB; Rosenberg M
Transplantation; 1993 Jan; 55(1):128-33. PubMed ID: 8093564
[TBL] [Abstract][Full Text] [Related]
40. Impairment of T-cell activation in head and neck cancer in situ and in vitro: strategies for an immune restoration.
Lang S; Whiteside TL; Lebeau A; Zeidler R; Mack B; Wollenberg B
Arch Otolaryngol Head Neck Surg; 1999 Jan; 125(1):82-8. PubMed ID: 9932594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]